Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Optimizing Ovarian Cancer Treatment and Prevention Through Parallel Germline and Somatic Genetic Testing.

Journal of the National Comprehensive Cancer Network : JNCCN - 1 Jun 2024

Kwon Janice S

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Predisposition to Disease
Share to Genetic Testing
Share to Germ-Line Mutation
Share to Ovarian Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38862010
DOI: 10.6004/jnccn.2024.7042

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 20 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Optimizing Ovarian Cancer Treatment and Prevention Through Parallel Germline and Somatic Genetic Testing.PMID 38862010Read ↗

Germline and somatic testing for ovarian Cancer: An SGO clinical practice statementSemantic proximity Read ↗

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline SummarySemantic proximity Read ↗

Identifying disparities in germline and somatic testing for ovarian cancerSemantic proximity Read ↗

Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients.Semantic proximity Read ↗

Genetic testing for epithelial ovarian cancer.Semantic proximity Read ↗

Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapiesSemantic proximity Read ↗

Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinicsSemantic proximity Read ↗

Next Generation Sequencing and Molecular Biomarkers in Ovarian Cancer—An Opportunity for Targeted TherapySemantic proximity Read ↗

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO GuidelineSemantic proximity Read ↗

Prevention of Ovarian Cancer: Where are We Now and Where are We Going?Semantic proximity Read ↗

Re-evaluating hereditary breast and ovarian cancer risk: clinical impact of updated multigene panel sequencing and genetic counseling.Semantic proximity Read ↗

Ovarian Cancer: From Precursor Lesion Identification to Population-Based Prevention ProgramsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.